# BioDrugs

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/biodrugs/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1172-7039 |
| ISSNs | 1172-7039,1173-8804,1179-190X,2195-8351 |
| OpenAlex ID | https://openalex.org/S143194599 |
| Publisher | Adis, Springer Healthcare |

## Journal papers

- [Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis](https://scholariq.org/papers/comparative-immunogenicity-of-tnf-inhibitors-impact-on-clinical-efficacy-and/)
- [Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)](https://scholariq.org/papers/efficacy-safety-and-immunogenicity-of-mb02-bevacizumab-biosimilar-versus/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.